Turkey made its first Vaccine for Coronavirus
While the coronavirus epidemic, which has affected millions of people in the world for months, has spread rapidly, vaccine trials have also begun. Following the "finding a vaccine" move from Russia first, other countries continue to work rapidly. The voluntary application of the coronavirus vaccine developed in China was launched in Brazil and Indonesia. The first coronavirus vaccine was made in Turkey at Hacettepe University Faculty and the vaccine was used for healthcare workers. The Phase 3 stage of these tests, including in Turkey began today.
The first coronavirus vaccine to health workers in Turkey
Turkey is actively in fight, and we met with over a thousand cases every day, the coronavirus vaccine studies were started as of today. These first vaccination studies, which started in Ankara, were carried out on healthcare workers most exposed to the virus.
According to the information in the news of CNN Turk, the vaccine developed by China-based Sinovac Biotech will be made to 1,200-1,300 healthcare personnel in the first place. In the second stage of this vaccine, the same people will be vaccinated once again after 14 days and the results will be shared with the World Health Organization (WHO).
The most important point of this vaccination process, which started on a voluntary basis, lies in bringing the same people back to the vaccine. Because this vaccine should be given to those who apply on a voluntary basis. The target is to vaccinate 13 thousand people with chronic diseases, where the virus has become more deadly.
According to the information provided by Haberturk writer Muharrem Sarıkaya, the vaccine will be made in other hospitals in Ankara, including Hacettepe, Ankara Hospital, and City Hospital.
Apart from Hacettepe, it is said that some hospitals in Ankara and Marmara in Istanbul and other private hospitals other than Istanbul University Faculty of Medicine hospital will start. In addition, some hospitals, including Izmir, Kayseri, Gaziantep and Malatya, were chosen as centers.